Two Sigma Securities, LLC Axsome Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $203,867 - $286,866	2,938 New	2,938 $234,000
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $121,828 - $299,573	-2,957 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $49,411 - $314,151	2,957 New	2,957 $306,000
Q2 2018 Aug 14, 2018	SELL	$2.15 - $3.6 $43,270 - $72,453	-20,126 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.35 - $5.6 $47,296 - $112,705	20,126 New	20,126 $49,000

327

37.8M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.94B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.